Natera, Inc.
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as tw…
Medical - Diagnostics & Research
US, San Carlos [HQ]
NTRA/Financial Reporting
Income Statements
11 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 55.00 | 159.00 | 190.00 | 217.00 | 210.00 | 257.00 | 302.00 | 391.00 | 625.00 | 820.00 | 1,082.00 | |
|
EPS
|
-1.01 | -0.14 | -2.68 | -1.86 | -2.56 | -2.22 | -1.79 | -2.84 | -5.21 | -5.57 | -3.78 | |
| Diluted in mil. | -1.01 | -0.14 | -2.68 | -1.86 | -2.54 | -2.22 | -1.79 | -2.84 | -5.21 | -5.57 | -3.78 | |
|
Profit
|
17.00 | 80.00 | 77.00 | 81.00 | 71.00 | 91.00 | 126.00 | 187.00 | 307.00 | 363.00 | 492.00 | |
| Gross Margin | 32.44 | 50.78 | 40.72 | 37.54 | 33.82 | 35.55 | 41.96 | 47.92 | 49.09 | 44.37 | 45.52 | |
| Pre Tax | -37.00 | -5.00 | -70.00 | -95.00 | -135.00 | -127.00 | -122.00 | -229.00 | -471.00 | -546.00 | -434.00 | |
| Profit Margin | -67.26 | -3.23 | -36.92 | -44.05 | -64.41 | -49.61 | -40.63 | -58.73 | -75.32 | -66.67 | -40.14 | |
| ETR | -32.44 | -48.58 | 14.12 | -0.15 | -0.33 | -0.25 | -1.63 | -0.04 | -0.13 | -0.18 | -0.06 | |
| Net | -37.00 | -5.00 | -70.00 | -95.00 | -136.00 | -128.00 | -124.00 | -229.00 | -471.00 | -547.00 | -434.00 | |
| Profit Margin | -67.26 | -3.23 | -36.92 | -44.12 | -64.62 | -49.74 | -41.29 | -58.76 | -75.42 | -66.79 | -40.16 | |
| EBITDA | -22.00 | 4.00 | -66.00 | -95.00 | -131.00 | -117.00 | -126.00 | -208.00 | -462.00 | -537.00 | -404.00 | |
| EBITDA Margin | -41.04 | 2.65 | -35.08 | -43.81 | -62.41 | -45.55 | -41.85 | -53.38 | -73.99 | -65.53 | -37.41 | |
| Operating Income | -25.00 | - - | -59.00 | -96.00 | -134.00 | -114.00 | -130.00 | -216.00 | -468.00 | -541.00 | -443.00 | |
| Operating Margin | -45.80 | 0.42 | -31.43 | -44.45 | -63.54 | -44.49 | -43.22 | -55.31 | -74.85 | -65.96 | -40.97 | |
| Interest Income | -2.00 | - - | - - | 1.00 | 2.00 | -2.00 | 4.00 | 7.00 | 5.00 | 3.00 | 24.00 | |
| Loss | -80.00 | -158.00 | -250.00 | -313.00 | -344.00 | -372.00 | -433.00 | -607.00 | -1,093.00 | -1,361.00 | -1,526.00 | |
| Cost of Revenue | -37.00 | -78.00 | -112.00 | -135.00 | -139.00 | -166.00 | -175.00 | -203.00 | -318.00 | -456.00 | -589.00 | |
|
Operating Expenses
|
-43.00 | -80.00 | -137.00 | -177.00 | -205.00 | -206.00 | -257.00 | -403.00 | -775.00 | -905.00 | -936.00 | |
| R&D | -11.00 | -17.00 | -27.00 | -41.00 | -50.00 | -51.00 | -51.00 | -100.00 | -264.00 | -316.00 | -317.00 | |
| G&A | - - | - - | -109.00 | -136.00 | -155.00 | -154.00 | - - | - - | - - | - - | - - | |
| SG&A | -31.00 | -62.00 | -109.00 | -136.00 | -155.00 | -154.00 | -206.00 | -303.00 | -511.00 | -588.00 | -618.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | -2.00 | -5.00 | -5.00 | -6.00 | -7.00 | -7.00 | -7.00 | -8.00 | -11.00 | -16.00 | -38.00 | |
| Interest Expenses | -11.00 | -4.00 | -3.00 | - - | -4.00 | -10.00 | -10.00 | -15.00 | -8.00 | -9.00 | -12.00 | |
| Other Expenses | - - | -1.00 | -7.00 | - - | -1.00 | -2.00 | -7.00 | -13.00 | -2.00 | -5.00 | -9.00 | |
|
WA Shares Outstanding
|
36.00 | 36.00 | 26.00 | 51.00 | 53.00 | 57.00 | 69.00 | 81.00 | 90.00 | 98.00 | 114.00 | |
| Diluted | 36.00 | 36.00 | 26.00 | 51.00 | 53.00 | 57.00 | 69.00 | 81.00 | 90.00 | 98.00 | 114.00 |